Piascik M F, Rahwan R G, Witiak D T
J Pharmacol Exp Ther. 1979 Jul;210(1):141-6.
The 2-n-propyl and 2-n-butyl aminoindene hydrochlorides were previously reported to interfere with excitation-contraction coupling in uterine and intestinal smooth muscle, and with stimulus-secretion coupling in the adrenal medulla, by interfering with the action of calcium at an intracellular site. The present investigation was designed to apply this knowledge to the potential coronary and cardiac effects of such a pharmacological action. The 2-n-propyl and 2-n-butyl aminoindenes (5 X 10(-6)-10(-4) M) produced a concentration-dependent relaxation of potassium-contracted strips of bovine extramural coronary vessels, which was reversible upon elevation of the calcium concentration in the medium. In the nonstimulated isolated perfused rabbit heart, the 2-n-propyl aminoindene (3 X 10(-5) M) and the 2-n-butyl aminoindene (3 X 10(-5) and 10(-4) M) increased coronary flow without affecting cardiac chronotropic activity. However, the 2-n-propyl aminoindene (3 X 10(-5) and 10(-4)M) and the 2-n-butyl aminoindene (10(-4) M) produced a negative inotropic action in this preparation. The combination of coronary dilation and decreased force of cardiac contraction may represent desirable properties for drugs useful in the treatment of ischemic heart disease.
据先前报道,2-正丙基和2-正丁基氨基茚盐酸盐通过干扰细胞内位点的钙作用,影响子宫和肠道平滑肌的兴奋-收缩偶联以及肾上腺髓质的刺激-分泌偶联。本研究旨在将这一知识应用于这种药理作用对冠状动脉和心脏的潜在影响。2-正丙基和2-正丁基氨基茚(5×10⁻⁶ - 10⁻⁴ M)可使牛壁外冠状动脉条带在钾收缩后产生浓度依赖性舒张,当培养基中钙浓度升高时这种舒张作用可逆。在未受刺激的离体灌注兔心脏中,2-正丙基氨基茚(3×10⁻⁵ M)和2-正丁基氨基茚(3×10⁻⁵ 和10⁻⁴ M)可增加冠状动脉血流量,而不影响心脏变时活性。然而,2-正丙基氨基茚(3×10⁻⁵ 和10⁻⁴ M)和2-正丁基氨基茚(10⁻⁴ M)在此制剂中产生负性肌力作用。冠状动脉扩张和心脏收缩力降低的联合作用可能代表了用于治疗缺血性心脏病的药物的理想特性。